Trust Company of Vermont’s Fresenius Medical Care FMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-160
| Closed | -$3.4K | – | 855 |
|
|
2023
Q1 | $3.4K | Hold |
160
| – | – | ﹤0.01% | 791 |
|
|
2022
Q4 | $2.61K | Hold |
160
| – | – | ﹤0.01% | 801 |
|
|
2022
Q3 | $2K | Hold |
160
| – | – | ﹤0.01% | 921 |
|
|
2022
Q2 | $4K | Buy |
+160
| New | +$4.78K | ﹤0.01% | 802 |
|
|
2022
Q1 | – | Sell |
-160
| Closed | -$5K | – | 461 |
|
|
2021
Q4 | $5K | Buy |
+160
| New | +$5.27K | ﹤0.01% | 721 |
|
|
2021
Q3 | – | Sell |
-160
| Closed | -$7K | – | 452 |
|
|
2021
Q2 | $7K | Hold |
160
| – | – | ﹤0.01% | 672 |
|
|
2021
Q1 | $6K | Hold |
160
| – | – | ﹤0.01% | 669 |
|
|
2020
Q4 | $7K | Hold |
160
| – | – | ﹤0.01% | 661 |
|
|
2020
Q3 | $7K | Hold |
160
| – | – | ﹤0.01% | 640 |
|
|
2020
Q2 | $7K | Hold |
160
| – | – | ﹤0.01% | 663 |
|
|
2020
Q1 | $5K | Hold |
160
| – | – | ﹤0.01% | 740 |
|
|
2019
Q4 | $6K | Hold |
160
| – | – | ﹤0.01% | 758 |
|
|
2019
Q3 | $5K | Hold |
160
| – | – | ﹤0.01% | 825 |
|
|
2019
Q2 | $6K | Hold |
160
| – | – | ﹤0.01% | 806 |
|
|
2019
Q1 | $6K | Sell |
160
-364
| -69% | -$13.6K | ﹤0.01% | 772 |
|
|
2018
Q4 | $17K | Hold |
524
| – | – | ﹤0.01% | 647 |
|
|
2018
Q3 | $27K | Hold |
524
| – | – | ﹤0.01% | 622 |
|
|
2018
Q2 | $26K | Hold |
524
| – | – | ﹤0.01% | 640 |
|
|
2018
Q1 | $27K | Hold |
524
| – | – | ﹤0.01% | 600 |
|
|
2017
Q4 | $28K | Hold |
524
| – | – | ﹤0.01% | 605 |
|
|
2017
Q3 | $26K | Hold |
524
| – | – | ﹤0.01% | 595 |
|
|
2017
Q2 | $25K | Hold |
524
| – | – | ﹤0.01% | 610 |
|
|
2017
Q1 | $22K | Hold |
524
| – | – | ﹤0.01% | 604 |
|
|
2016
Q4 | $22K | Hold |
524
| – | – | ﹤0.01% | 600 |
|
|
2016
Q3 | $23K | Hold |
524
| – | – | ﹤0.01% | 549 |
|
|
2016
Q2 | $23K | Hold |
524
| – | – | ﹤0.01% | 500 |
|
|
2016
Q1 | $23K | Hold |
524
| – | – | ﹤0.01% | 503 |
|
|
2015
Q4 | $22K | Hold |
524
| – | – | ﹤0.01% | 519 |
|
|
2015
Q3 | $20K | Hold |
524
| – | – | ﹤0.01% | 534 |
|
|
2015
Q2 | $22K | Hold |
524
| – | – | ﹤0.01% | 540 |
|
|
2015
Q1 | $22K | Hold |
524
| – | – | ﹤0.01% | 531 |
|
|
2014
Q4 | $19K | Hold |
524
| – | – | ﹤0.01% | 561 |
|
|
2014
Q3 | $18K | Hold |
524
| – | – | ﹤0.01% | 562 |
|
|
2014
Q2 | $18K | Hold |
524
| – | – | ﹤0.01% | 539 |
|
|
2014
Q1 | $18K | Hold |
524
| – | – | ﹤0.01% | 529 |
|
|
2013
Q4 | $19K | Hold |
524
| – | – | ﹤0.01% | 492 |
|
|
2013
Q3 | $17K | Hold |
524
| – | – | ﹤0.01% | 488 |
|
|
2013
Q2 | $18K | Buy |
+524
| New | +$18.2K | ﹤0.01% | 483 |
|
Other funds holding FMS
FMI
TBC
Trust Company of Vermont's FMS Position: Q2 2023 in Review
Trust Company of Vermont sold out of Fresenius Medical Care (FMS) in Q2 2023, closing a stake of 160 shares — an estimated $3.4K sold.
Trust Company of Vermont first reported a position in FMS in Q2 2013 and held it in 38 quarters. The position peaked at $28K in Q4 2017. 146 funds tracked by Wall St. Rank hold FMS as of Q2 2023.
- Trust Company of Vermont reported no remaining Fresenius Medical Care position as of Q2 2023 after selling out during the quarter.
- Trust Company of Vermont sold 160 Fresenius Medical Care shares in Q2 2023, an estimated $3.4K.
- Trust Company of Vermont first reported a position in Fresenius Medical Care in Q2 2013 and held it in 38 quarters.
- Trust Company of Vermont's Fresenius Medical Care position peaked at $28K in Q4 2017.
- 146 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2023.
Based on Trust Company of Vermont's 13F filing for Q2 2023, filed 17 Jul 2023.